A positron emission tomography study to investigate peripheral benzodiazepine receptor occupancy following single oral doses of SSR180575 in healthy male subjects
Latest Information Update: 21 Feb 2006
At a glance
- Drugs SSR 180575 (Primary)
- Indications Arthritis; Diabetic neuropathies; Heart failure; Neurodegenerative disorders
- Focus Pharmacodynamics
- 21 Feb 2006 New trial record.